Alzheimer's Disease

Human head and brain
Isaac Health, LillyDirect partner for dementia platform
By Anthony Vecchione | 09:17 am | October 22, 2025
The companies said that being listed as a provider on LillyDirect will expand patient access to Isaac Health care.
The funds will be used to increase the development of GAIA-based Alzheimer's disease drugs and widen the pipeline of blockbuster drug candidates.
Illimis Therapeutics secures $42M for CNS and immune disease therapies
By Anthony Vecchione | 01:07 pm | July 16, 2025
The funds will be used to increase the development of GAIA-based Alzheimer's disease drugs and widen the pipeline of blockbuster drug candidates.